Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Non-Current Assets (2023 - 2025)

Baird Medical Investment Holdings has reported Non-Current Assets over the past 3 years, most recently at $14.7 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 10.97% year-over-year to $14.7 million; the TTM value through Dec 2025 reached $14.7 million, down 10.97%, while the annual FY2025 figure was $14.7 million, 10.97% down from the prior year.
  • Non-Current Assets for Q4 2025 was $14.7 million at Baird Medical Investment Holdings, down from $16.2 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $16.6 million in Q4 2023 and troughed at $14.7 million in Q4 2025.
  • A 3-year average of $16.0 million and a median of $16.4 million in 2024 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: decreased 0.47% in 2024 and later fell 10.97% in 2025.
  • Year by year, Non-Current Assets stood at $16.6 million in 2023, then dropped by 0.47% to $16.5 million in 2024, then dropped by 10.97% to $14.7 million in 2025.
  • Business Quant data shows Non-Current Assets for BDMD at $14.7 million in Q4 2025, $16.2 million in Q2 2025, and $16.5 million in Q4 2024.